Strategy aims to overcome RP heterogeneity using gene therapy treatment with dominant retinitis pigmentosa
Researchers at the Scheie Eye Institute, University of Pennsylvania, has reported that a mutation-independent strategy for treating autosomal dominant retinitis pigmentosa (adRP) prevents photoreceptor cell… Read More »Strategy aims to overcome RP heterogeneity using gene therapy treatment with dominant retinitis pigmentosa